Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) dropped 5.5% on Wednesday . The company traded as low as $3.24 and last traded at $3.25, with a volume of 114,507 shares traded. The stock had previously closed at $3.44.

Separately, Maxim Group reaffirmed a “buy” rating and set a $6.00 price target on shares of Onconova Therapeutics in a report on Friday, August 19th.

The stock has a 50-day moving average price of $3.84 and a 200-day moving average price of $4.68. The company’s market capitalization is $20.61 million.

Onconova Therapeutics (NASDAQ:ONTX) last posted its quarterly earnings data on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share (EPS) for the quarter. The company had revenue of $2.25 million for the quarter. On average, equities analysts anticipate that Onconova Therapeutics Inc. will post ($2.15) earnings per share for the current year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.